The results indicated that the mRNA level of SAP130 was negatively correlated with that of FAF1 in several types of cancer, such as diffuse large B-cell lymphoma (Person correlation: -0.45; p < 0.001), prostate adenocarcinoma (Person correlation: -0.37; p < 0.001), thyroid carcinoma (Person correlation: -0.17; p < 0.001) and colorectal adenocarcinoma (Person correlation: -0.13; p < 0.001) (Fig. 5). This evidence concerns the gene FAF1 and prostate adenocarcinoma.